Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.41 |
| ▸ | ACACB | O00763 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 2/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | LDHA | P00338 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20214592 | 0.85 | PTGS2 (0.51) | RAB9ANPC1PTGS2 | |
| SCHEMBL10847599 | 0.80 | ACACB (0.42) | ACACBLDHA | |
| SCHEMBL9326256 | 0.80 | RAB9A (0.63) | CYP1A2RAB9ANPC1SMN1; SMN2ACHE | |
| SCHEMBL10743703 | 0.78 | HSD17B10 (0.50) | ACACBELANE | |
| SCHEMBL11218143 | 0.78 | PPARG (0.44) | LDHA | |
| SCHEMBL9356465 | 0.78 | PPARG (0.44) | LDHA | |
| SCHEMBL10642349 | 0.78 | ALDH1A1 (0.55) | CYP1A2RAB9ANPC1ADAMTS4SMN1; SMN2 | |
| SCHEMBL12893245 | 0.77 | ALDH1A1 (0.51) | RAB9ANPC1ADAMTS4SMN1; SMN2ACHE | |
| SCHEMBL2803010 | 0.77 | SLC7A5 (0.57) | CYP1A2SMN1; SMN2ACHEALDH1A1LDHA | |
| SCHEMBL9325570 | 0.77 | THRB (0.60) | RAB9ANPC1ACACBSMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230301302-A1 | AGROCHEMICAL ADJUVANTS | CRODA INTERNATIONAL PLC (GB) | 2023-09-28 | — | — | US | disclosed |
| US-20210204541-A1 | SPRAY DRIFT REDUCTION | CRODA, INC. (US) | 2021-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230301302-A1 | AGROCHEMICAL ADJUVANTS | IL5, TLR5, DDT | CYP1A2 1435/4885RAB9A 3073/4885NPC1 4226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.